Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

May 12, 2008

Primary Completion Date

September 6, 2011

Study Completion Date

January 10, 2013

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

cetuximab

cetuximab (Erbitux®) - Initial dose - Day 1 (Week 1): 400 mg/m2 IV over 120 minutes Maintenance Infusions (subsequent weeks): 250 mg/m2 IV over 60 minutes

DRUG

brivanib alaninate

brivanib (BMS-582664) 800 mg po, QD

Trial Locations (37)

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V2S 0C2

BCCA - Abbotsford Centre, Abbotsford

V1Y 5L3

BCCA - Cancer Centre for the Southern Interior, Kelowna

V3V 1Z2

BCCA - Fraser Valley Cancer Centre, Surrey

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

R3E 0V9

CancerCare Manitoba, Winnipeg

E1C 6Z8

The Moncton Hospital, Moncton

E1C 8X3

The Vitalite Health Network - Dr. Leon Richard, Moncton

E2L 4L2

Atlantic Health Sciences Corporation, Saint John

AIB 3V6

Dr. H. Bliss Murphy Cancer Centre, St. John's

L4M 6M2

The Royal Victoria Hospital, Barrie

L8V 5C2

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

K7L 5P9

Cancer Centre of Southeastern Ontario at Kingston, Kingston

N2G 1G3

Grand River Regional Cancer Centre, Kitchener

N6A 4L6

London Regional Cancer Program, London

L3Y 2P9

Stronach Regional Health Centre at Southlake, Newmarket

L1G 2B9

Lakeridge Health Oshawa, Oshawa

K1H 8L6

Ottawa Health Research Institute - General Division, Ottawa

P6B 0A8

Algoma District Cancer Program, Sault Ste. Marie

L2R 7C6

Niagara Health System, St. Catharines

P7B 6V4

Thunder Bay Regional Health Science Centre, Thunder Bay

M4C 3E7

Toronto East General Hospital, Toronto

M4N 3M5

Odette Cancer Centre, Toronto

M5B 1W8

St. Michael's Hospital, Toronto

M5G 2M9

Univ. Health Network-Princess Margaret Hospital, Toronto

C1A 8T5

PEI Cancer Treatment Centre,Queen Elizabeth Hospital, Charlottetown

J4V 2H1

Hopital Charles LeMoyne, Greenfield Park

G6V 3Z1

L'Hotel-Dieu de Levis, Lévis

H2L 4M1

CHUM - Hopital Notre-Dame, Montreal

H2W 1S6

McGill University - Dept. Oncology, Montreal

H4J 1C5

Hopital du Sacre-Coeur de Montreal, Montreal

G1R 2J6

CHUQ-Pavillon Hotel-Dieu de Quebec, Québec

G1S 4L8

CHA-Hopital Du St-Sacrement, Québec

J1H 5N4

Centre hospitalier universitaire de Sherbrooke, Sherbrooke

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK